Thank you to the presenters who agreed to make their presentations at the 9th International Conference on HHV-6 & 7 available to others.
HHV-6 ANTIVIRAL THERAPY
The Difficult Path Towards an HHV-6 Therapy
Lieve Naesens, PhD, Laboratory of Virology and Chemotherapy, Rega Institute, KU Leuven, Belgium
DIAGNOSTICS
Diagnostic Tools and Algorithms for HHV-6 Infections in Immunocompromised Patients
Agnes Gautheret Dejean, MD, PhD, Groupe Hospitalier Pitie-Salpetriere, France
Detection of HHV-6B Reactivation in Hematopoietic Cell Transplant Recipients with Inherited Chromosomally Integrated HHV-6A by Droplet Digital PCR
Ruth Hall-Sedlak, PhD, University of Washington, USA
HHV-6 in TRANSPLANTATION
HHV-6 Disease in Immunocompromised Patients
Danielle Zerr, MD, Children’s Hospital of Seattle, University of Washington
Guidelines for Treatment of HHV-6 Infections in Immunocompromised Patients
Per Ljungman, MD, PhD, Karolinska Institute, Sweden
CNS DISEASE
CNS Manifestations at the Time of Primary HHV-6B Infection: Pathogenesis and Possibility of Antiviral Treatment
Tetsushi Yoshikawa, MD, PhD, Fujita Health University School of Medicine, Japan
HHV6-B in Febrile Seizures and Medial Temporal Lobe Epilepsy
Jeffrey Cohen, MD, National Institutes of Health, USA
HHV-6 IN THE IMMUNOCOMPETENT
Diseases to Which HHV-6 May Be Linked…and the Difficulties of Linking a Ubiquitous Virus to Disease
Anthony Komaroff, MD, Harvard Medical School, USA
Possible Mechanisms of HHV-6 Reactivation in DIHS/DRESS
Hideo Hashizume, MD, PhD, Shimada Municipal Hospital, Japan
HHV-6 Lymphadenitis in DRESS Syndrome: A Case Report
David Hudnall, MD, FCAP, Yale University School of Medicine, USA
CHROMOSOMALLY INTEGRATED HHV-6
Introduction to Human Herpesvirus 6 and Inherited Chromosomally Integrated HHV-6
Louis Flamand, PhD, Universite Laval, Canada
HHV-6A HHV-6B and HHV-7 Sequences in the 1000 Genomes Project Database
Peter Medveczky, MD, University of South Florida, USA
Efficient Identification of Chromosomally Integrated Human Herpesvirus 6 Using Specimen Pooling
Joshua Hill, MD, Fred Hutchinson Cancer Research Center and University of Washington, USA
Large-Scale Population Study of Chronic Diseases Associated with Inherited Chromosomally-Integrated HHV-6
Louis Flamand, PhD, Universite Laval, Canada
Target Enrichment as a Tool for Studying ciHHV6
Marco Telford, MSc, University Pompeu Fabra, Spain
The Analysis of the Origin of Chromosomally Integrated Human Herpesvirus 6
Yoshiki Kawamura, MD, PhD, Center for Biologics Evaluation and Research, Food and Drug Administration, USA
IMMUNITY
Characterizing the CD4 T Cell Response to HHV-6B
Mauricio Calvo-Calle, PhD, University of Massachusetts Medical School, USA
EPIDEMIOLOGY
Primary HHV-6 Infection in African Infants
Soren Gantt, MD, PhD, MPH, University of British Columbia Child & Family Research Institute, Canada (Note: By permission only. Contact: admin@HHV-6foundation.org)
ANIMAL MODELS
Characterization of the HHV-6A Brain Infection in CD46-transgenic Mice
Branka Horvat, MD, PhD, National Institute Of Health and Medical Research (INSERM), France (Note: By permission only. Contact: admin@HHV-6foundation.org)
HHV-6 & MALIGNANCY
HHV-6A, HHV-6B, CMV, EBV Multiplexed ddPCR Screening in Brain Tissue from Low- and High-Grade Astrocytoma Cases and Controls
Chang-Te Major Lin, MPH, NIH; NINDS, USA (Note: By permission only. Contact: admin@HHV-6foundation.org)
GENES & PROTEINS
Interactions Between U24 from HHV-6A and 7 and WW Domains
Suzana Straus, PhD, University of British Columbia, Canada (Note: By permission only. Contact: admin@HHV-6foundation.org)